Stop Livin to make lymphoma cells stop living

(University of Tsukuba) Researchers at the University of Tsukuba have shown that the protein Livin, an inhibitor of apoptosis or programmed cell death, mediates resistance to immunotherapy in some lymphoma variants. Therapeutically targeting Livin with IAP inhibitors or BET inhibitors may provide a practical strategy for patients with Livin-positive and other refractory B-cell lymphomas.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news